Immunovant (IMVT) Cash from Investing Activities (2019 - 2026)
Immunovant (IMVT) recorded Cash from Investing Activities of -$8,000 in fiscal Q4 2026 (quarter ended Mar 31, 2026), compared with -$201,000 a year earlier.
Powered by 
Analysis
Immunovant (IMVT) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Starting with fiscal Q1 2020, Immunovant's Cash from Investing Activities history includes 25 quarters.
- Across earlier fiscal years, Cash from Investing Activities came in at -$759,000 in FY2025, -$360,000 in FY2024, -$197,000 in FY2023 and -$254,000 in FY2022.
- The fiscal Q4 2026 figure is the highest quarterly Cash from Investing Activities in data going back to fiscal Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Immunovant | 6.93 Bn | 6.93 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -8,000.00 |
| Mar 31, 2025 | -201,000.00 |
| Dec 31, 2024 | -180,000.00 |
| Sep 30, 2024 | -196,000.00 |
| Jun 30, 2024 | -182,000.00 |
| Mar 31, 2024 | -150,000.00 |
| Dec 31, 2023 | -131,000.00 |
| Sep 30, 2023 | -34,000.00 |
| Jun 30, 2023 | -45,000.00 |
| Mar 31, 2023 | -26,000.00 |
| Dec 31, 2022 | -98,000.00 |
| Sep 30, 2022 | -31,000.00 |
| Jun 30, 2022 | -42,000.00 |
| Mar 31, 2022 | -118,000.00 |
| Dec 31, 2021 | -74,000.00 |
| Sep 30, 2021 | -44,000.00 |
| Jun 30, 2021 | -18,000.00 |
| Mar 31, 2021 | -95,000.00 |
| Dec 31, 2020 | -29,000.00 |
| Sep 30, 2020 | -39,000.00 |
API Access
Immunovant Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();